Exact Sciences Statistics
Total Valuation
Exact Sciences has a market cap or net worth of $7.97 billion. The enterprise value is $9.87 billion.
| Market Cap | 7.97B |
| Enterprise Value | 9.87B |
Important Dates
The next estimated earnings date is Tuesday, July 30, 2024, after market close.
| Earnings Date | Jul 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Exact Sciences has 184.53 million shares outstanding. The number of shares has increased by 2.11% in one year.
| Shares Outstanding | 184.53M |
| Shares Change (YoY) | +2.11% |
| Shares Change (QoQ) | +0.68% |
| Owned by Insiders (%) | 0.98% |
| Owned by Institutions (%) | 90.17% |
| Float | 183.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.14 |
| Forward PS | 2.67 |
| PB Ratio | 2.54 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.89 |
| EV / EBITDA | 301.19 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.82.
| Current Ratio | 1.64 |
| Quick Ratio | 1.30 |
| Debt / Equity | 0.82 |
| Debt / EBITDA | 77.98 |
| Debt / FCF | n/a |
| Interest Coverage | -6.55 |
Financial Efficiency
Return on equity (ROE) is -7.70% and return on invested capital (ROIC) is -4.30%.
| Return on Equity (ROE) | -7.70% |
| Return on Assets (ROA) | -3.80% |
| Return on Capital (ROIC) | -4.30% |
| Revenue Per Employee | $384,067 |
| Profits Per Employee | -$36,398 |
| Employee Count | 6,600 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 5.28 |
Taxes
In the past 12 months, Exact Sciences has paid $2.55 million in taxes.
| Income Tax | 2.55M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.76% in the last 52 weeks. The beta is 1.26, so Exact Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 1.26 |
| 52-Week Price Change | -53.76% |
| 50-Day Moving Average | 50.29 |
| 200-Day Moving Average | 61.57 |
| Relative Strength Index (RSI) | 43.17 |
| Average Volume (20 Days) | 3,083,713 |
Short Selling Information
The latest short interest is 9.45 million, so 5.12% of the outstanding shares have been sold short.
| Short Interest | 9.45M |
| Short Previous Month | 8.78M |
| Short % of Shares Out | 5.12% |
| Short % of Float | 5.16% |
| Short Ratio (days to cover) | 3.11 |
Income Statement
In the last 12 months, Exact Sciences had revenue of $2.53 billion and -$240.23 million in losses. Loss per share was -$1.32.
| Revenue | 2.53B |
| Gross Profit | 1.87B |
| Operating Income | -244.61M |
| Pretax Income | -237.67M |
| Net Income | -240.23M |
| EBITDA | 32.77M |
| EBIT | -206.18M |
| Loss Per Share | -$1.32 |
Balance Sheet
The company has $652.09 million in cash and $2.56 billion in debt, giving a net cash position of -$1.90 billion or -$10.31 per share.
| Cash & Cash Equivalents | 652.09M |
| Total Debt | 2.56B |
| Net Cash | -1.90B |
| Net Cash Per Share | -$10.31 |
| Equity (Book Value) | 3.13B |
| Book Value Per Share | 16.98 |
| Working Capital | 435.16M |
Cash Flow
In the last 12 months, operating cash flow was $112.02 million and capital expenditures -$132.48 million, giving a free cash flow of -$20.46 million.
| Operating Cash Flow | 112.02M |
| Capital Expenditures | -132.48M |
| Free Cash Flow | -20.46M |
| FCF Per Share | -$0.11 |
Margins
Gross margin is 73.67%, with operating and profit margins of -9.65% and -9.48%.
| Gross Margin | 73.67% |
| Operating Margin | -9.65% |
| Pretax Margin | -9.38% |
| Profit Margin | -9.48% |
| EBITDA Margin | 1.29% |
| EBIT Margin | -8.13% |
| FCF Margin | -0.81% |
Dividends & Yields
Exact Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.11% |
| Shareholder Yield | -2.11% |
| Earnings Yield | -3.02% |
| FCF Yield | -0.26% |
Analyst Forecast
The average price target for Exact Sciences is $88.33, which is 104.61% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $88.33 |
| Price Target Difference | 104.61% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 12.07% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Exact Sciences has an Altman Z-Score of 1.06 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.06 |
| Piotroski F-Score | 5 |